Gallotannin isolated from Euphorbia species, 1,2,6-tri-O-galloyl-β-D- allose, decreases nitric oxide production through inhibition of nuclear factor- κB and downstream inducible nitric oxide synthase expression in macrophages

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 6, 2009, Pages 1053-1056

  Kim, Mi Sun ^a   Park, Seung Bin ^a   Suk, Kyoungho ^a   Kim, In Kyeom ^a   Kim, Sang Yong ^b   Kim, Jeong Ah ^c   Lee, Seung Ho ^c   Kim, Sang Hyun ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Korea National Arboretum   (South Korea)

^c Yeungnam University   (South Korea)

Author keywords

1,2,6 tri O galloyl D allose; Euphorbia species; Gallotannin; Inflammation; Nitric oxide; Nuclear factor B

Indexed keywords

1 O GALLOYL BETA DEXTRO GLUCOSE; 1,2,3 TRI O GALLOYL BETA DEXTRO GLUCOSE; 1,2,3,4,6 PENTA O GALLOYL BETA DEXTRO GLUCOSE; 1,2,6 TRI O GALLOYL BETA DEXTRO ALLOSE; 1,3,6 TRI O GALLOYL BETA DEXTRO ALLOSE; 2 O GALLOYL DEXTRO GALACTOSE; 3 O GALLOYL QUINIC ACID; EUPHORBIA EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITROBLUE TETRAZOLIUM; TANNIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CELL VIABILITY; DOSE RESPONSE; DRUG MECHANISM; ENZYME INHIBITION; EUPHORBIA; GENE EXPRESSION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOTTING, WESTERN; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; EUPHORBIA; GALLIC ACID; GENE EXPRESSION; GLUCOSE; HYDROLYZABLE TANNINS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 66549102572     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.1053     Document Type: Article

References (33)

1. Gross S. S., Wolin M. S., Annu. Rev. Physiol., 57, 737-769 (1995).
2. Kim S. H., Johnson V. J., Sharma R. P., Nitric Oxide, 7, 67-74 (2002).
3. Kim S. H., Kim J., Sharma R. P., Pharmacol. Res., 49, 433-439 (2004).
4. Liu P. T., Modlin R. L., Curr. Opin. Immunol., 20, 371-376 (2008).
5. Xie Q. W., Kashiwabara Y., Nathan C., J. Biol. Chem., 269, 4705-4708 (1994).
6. Kim S. H., Jun C. D., Suk K., Choi B. J., Lim H., Park S., Lee S. H., Shin H. Y., Kim D. K. Shin T. Y., Toxicol. Sci., 91, 123-131 (2006).
7. Erdelyi K., Kiss A., Bakondi E., Bai P., Szabo C., Gergely P., Erdodi F., Virag L., Mol. Pharmacol., 68, 895-904 (2005).
8. Li M., Kai Y., Qiang H., Dongying J., J. Basic Microbiol., 46, 68-84 (2006).
9. Rapizzi E., Fossati S., Moroni F. Chiarugi A., Mol. Pharmacol., 66, 890-898 (2004).
10. Hagerman A. E., Riedl K. M., Rice R. E., Basic Life Sci., 66, 495-505 (1999).
11. Feldman K. S., Sahasrabudhe K., Lawlor M. D., Wilson S. L., Lang C. H., Scheuchenzuber W. J., Bioorg. Med. Chem. Lett., 11, 1813-1815 (2001).
12. Lee S. H., Tanaka T., Nonaka G. I., Nishioka I., Phytochemistry, 30, 1251-1253 (1991).
13. Lee S. H., Tanaka T., Nonaka G. I., Nishioka I., Chem. Pharm. Bull., 39, 630-638 (1991).
14. Lee S. J., Lee I. S., Mar W., Arch. Pharm. Res., 26, 832-839 (2003).
15. Pan M. H., Lin-Shiau S. Y., Ho C. T., Lin J. H., Lin J. K., Biochem. Pharmacol., 59, 357-367 (2000).
16. Kim S. H., Lee S., Suk K., Bark H., Jun C. D., Kim D. K., Choi C. H., Yoshimura T., Free Radic. Biol. Med., 42, 343-352 (2007).
17. Kim S. H., Sharma R. P., Toxicol. Appl. Pharmacol., 196, 47-57 (2004).
18. Kim S. H., Choi C. H., Kim S. Y., Eun J. S., Shin T. Y., Exp. Biol. Med. (Maywood), 230, 82-88 (2005).
19. Kim S. H., Shin T. Y., Exp. Biol. Med. (Maywood), 230, 681-687 (2005).
20. Lee S., Suk K., Kim I. K., Jang I. S., Park J. W., Johnson V. J., Kwon T. K., Choi B. J., Kim S. H., J. Neurosci. Res., 86, 2932-2942 (2008).
21. Abad M. J., Bessa A. L., Ballarin B., Aragon O., Gonzales E., Bermejo P., J. Ethnopharmacol., 103, 338-344 (2006).
22. Calixto J. B., Campos M. M., Otuki M. F., Santos A. R., Planta Med., 70, 93-103 (2004).
23. Hohmann J., Redei D., Forgo P., Molnar J., Dombi G., Zorig T., J. Nat. Prod., 66, 976-979 (2003).
24. Hohmann J., Molnar J., Redei D., Evanics F., Forgo P., Kalman A., Argay G., Szabo P., J. Med. Chem., 45, 2425-2431 (2002).
25. Engi H., Vasas A., Redei D., Molnar J., Hohmann J., Anticancer Res., 27, 3451-3458 (2007).
26. Ahn M. J., Kim C. Y., Lee J. S., Kim T. G., Kim S. H., Lee C. K., Lee B. B., Shin C. G., Huh H., Kim J., Planta Med., 68, 457-459 (2002).
27. Hu H., Lee H. J., Jiang C., Zhang J., Wang L., Zhao Y., Xiang Q., Lee E. O., Kim S. H., Lu J., Mol. Cancer Ther., 7, 2681-2691 (2008).
28. Park E. J., Zhao Y. Z., An R. B., Kim Y. C., Sohn D. H., Planta Med., 74, 1380-1383 (2008).
29. Oh G. S., Pae H. O., Choi B. M., Jeong S., Oh H., Oh C. S., Rho Y. D., Kim D. H., Shin M. K., Chung H. T., J. Ethnopharmacol., 84, 85-89 (2003).
30. Oh G. S., Pae H. O., Choi B. M., Lee H. S., Kim I. K., Yun Y. G., Kim J. D., Chung H. T., Int. Immunopharmacol., 4, 377-386 (2004).
31. Kang D. G., Moon M. K., Choi D. H., Lee J. K., Kwon T. O., Lee H. S., Eur. J. Pharmacol., 524, 111-119 (2005).
32. Lee S. H., Park H. H., Kim J. E., Kim J. A., Kim Y. H., Jun C. D., Kim S. H., Planta Med., 73, 769-773 (2007).
33. Lee J., Lee S. H., Min K. R., Lee K. S., Ro J. S., Ryu J. C., Kim Y., Planta Med., 59, 381-382 (1993).